Mar 30, 2017 12:32 pm UTC| Business
BRIDGEWATER, N.J., March 30, 2017 -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced the publication of an article that highlights the benefit of diabetes medication delivery devices, including Valeritas’ V-Go®...
Mar 30, 2017 12:32 pm UTC| Business
BRIDGEWATER, N.J., March 30, 2017 -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced the publication of an article that highlights the benefit of diabetes medication delivery devices, including Valeritas’ V-Go®...
Mar 30, 2017 12:32 pm UTC| Business
MADISON, Wis., March 30, 2017 -- Madison, Wis. Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused clinical stage biotechnology company, today announces the initiation of a Phase II clinical study of its lead...
Mar 30, 2017 12:32 pm UTC| Business
MADISON, Wis., March 30, 2017 -- Madison, Wis. Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused clinical stage biotechnology company, today announces the initiation of a Phase II clinical study of its lead...
Mar 30, 2017 12:32 pm UTC| Business
MADISON, Wis., March 30, 2017 -- Madison, Wis. Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused clinical stage biotechnology company, today announces the initiation of a Phase II clinical study of its lead...
Mar 30, 2017 12:31 pm UTC| Business
CAMBRIDGE, Mass., March 30, 2017 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment...
Mar 30, 2017 12:31 pm UTC| Business
CAMBRIDGE, Mass., March 30, 2017 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment...
US–India Trade Talks Race Toward USD 500 Billion Goal